These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3628023)

  • 21. [Exhalation of I-131 after radioiodine therapy (RIT): time dependence and chemical form].
    Schomäcker K; Fischer T; Eschner W; Gaidouk MI; Schicha H
    Nuklearmedizin; 2001 Feb; 40(1):15-22. PubMed ID: 11373934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is it safe to work with iodine-131 if you are pregnant? A risk assessment for nuclear medicine staff involved with cleaning and decontamination.
    Barber RW; Parkin A; Goldstone KE
    Nucl Med Commun; 2003 May; 24(5):571-4. PubMed ID: 12717076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid discharges from patients undergoing 131I treatments.
    Barquero R; Basurto F; Nuñez C; Esteban R
    J Environ Radioact; 2008 Oct; 99(10):1530-4. PubMed ID: 18243440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of Ozone (CAS No. 10028-15-6) and Ozone/NNK (CAS No. 10028-15-6/ 64091-91-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Oct; 440():1-314. PubMed ID: 12595923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population dose in the vicinity of closed Hungarian uranium mine.
    Gorjánácz Z; Várhegyi A; Kovács T; Somlai J
    Radiat Prot Dosimetry; 2006; 118(4):448-52. PubMed ID: 16436520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioiodine treatment of feline hyperthyroidism in Germany.
    Puille M; Knietsch M; Spillmann T; Grünbaum EG; Bauer R
    Nuklearmedizin; 2002 Dec; 41(6):245-51. PubMed ID: 12520661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Measurement of incorporation in family members of radioiodine therapy patients after therapy of benign thyroid diseases].
    Lassmann M; Hänscheid H; Schelper LF; Körber C; Reiners C
    Nuklearmedizin; 1998 May; 37(3):120-3. PubMed ID: 9604233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
    Tuttle RM; Leboeuf R; Robbins RJ; Qualey R; Pentlow K; Larson SM; Chan CY
    J Nucl Med; 2006 Oct; 47(10):1587-91. PubMed ID: 17015892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External dose rates in radioiodine treatment of benign goitre: estimation versus direct measurement.
    Jørgensen HB; Høilund-Carlsen PF; Nielsen VE
    Scand J Clin Lab Invest; 2006; 66(6):509-16. PubMed ID: 17000558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. External radiation doses to nuclear medicine technologists from procedures using 99mTc radiopharmaceuticals.
    Boutcher S; Haas T
    Can J Radiogr Radiother Nucl Med; 1985 Oct; 16(4):161-5. PubMed ID: 10274037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishing a threshold for 131I bioassay in nuclear medicine personnel.
    Liang Y; Chu RY; Galbraith WK; Macdurmon GW; Sonnad JR
    Health Phys; 2008 Nov; 95(5 Suppl):S175-9. PubMed ID: 18849711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a voxel phantom as a source and a second voxel phantom as a target to calculate effective doses in individuals exposed to patients treated with 131I.
    de Carvalho AB; Hunt J; Silva AX; Garcia F
    J Nucl Med Technol; 2009 Mar; 37(1):53-6. PubMed ID: 19223425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The treatment of thyroid diseases using 131I in a special ward with a liquid waste storage plant].
    Wellner U; Schicha H
    Nuklearmedizin; 1993 Jun; 32(3):149-55. PubMed ID: 8327334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is the post-therapeutic dosimetry of patients with short-term hospitalization after 131I therapy sufficiently reliable?].
    Körber C; Schneider P; Hänscheid H; Köck PR; Reiners C
    Nuklearmedizin; 2000; 39(1):9-12. PubMed ID: 10726251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study on external exposure doses from terrestrial radioactivity in Southern Vietnam.
    Huy NQ; Luyen TV
    Radiat Prot Dosimetry; 2006; 118(3):331-6. PubMed ID: 16143724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [External exposure of hot cell operators in nuclear medicine].
    Sichirollo AE; Bombardieri E; Cortona G; Marchesini R
    Radiol Med; 1998 Dec; 96(6):612-7. PubMed ID: 10189927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exhalation of
    Sudbrock F; Fischer T; Zimmermanns B; Drzezga A; Schomäcker K
    J Environ Radioact; 2017 Jan; 166(Pt 1):162-165. PubMed ID: 27405239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of patient attenuation factor for iodine-131 based on direct dose rate measurements from radioiodine therapy patients.
    Soliman K; Alenezi A
    Nucl Med Commun; 2015 Feb; 36(2):125-8. PubMed ID: 25279710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.